Personalized Diabetes Management System Using Dynamic Feedback
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current clinical approaches for managing chronic diseases like diabetes lack integration of patient-specific factors, such as physiological variability, metabolic differences, and the effects of stress, exercise, and meals, leading to inefficiencies in insulin therapy and glucose control.
Innovation Solution
A computerized system and method that collects and analyzes patient-specific metabolic, physiological, and lifestyle data to provide tailored therapies and prognosis, using dynamic modeling and patient-specific models to determine optimal insulin delivery and glucose management.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If population-based clinical trials are used to determine drug dosage, then generalizability to target population is improved, but patient-specific variability in pharmacokinetics and pharmacodynamics is not adequately addressed
Solution Approach 1:
The system implements continuous feedback loops where glucose measurements from patients are collected, analyzed, and used to adjust insulin dosage recommendations. This feedback mechanism allows the system to adapt to individual patient responses while maintaining population-based guidelines as the foundation, thereby resolving the contradiction between generalizability and patient-specific accuracy
Solution Approach 2:
The system transitions from static population-based dosage guidelines to dynamic, real-time dosage adjustment based on continuous glucose monitoring data. This dynamic approach allows insulin recommendations to adapt continuously to changing patient conditions, physiological states, and individual response patterns, addressing both population-level and individual-level needs
2Ease of operation
If conventional therapy with fixed insulin dosage guidelines is used, then ease of implementation is improved, but inability to account for patient-specific factors such as physiological variability and metabolic differences reduces therapy effectiveness
Solution Approach 1:
The system introduces a computational intermediary layer between fixed clinical guidelines and patient-specific therapy decisions. This intermediary uses algorithms to process continuous glucose data, patient characteristics, and guideline parameters, generating personalized insulin recommendations that maintain the simplicity of guideline-based approaches while incorporating individual patient variability
Solution Approach 2:
The system enables patients to actively participate in their own therapy management by providing real-time glucose data and receiving personalized insulin dosage recommendations. This self-service approach empowers patients to adjust their therapy based on their individual needs while maintaining alignment with clinical guidelines, thereby improving both ease of implementation and therapy effectiveness
3Adaptability or versatility
If trial-and-error approach is used for insulin dosage adjustment, then adaptability to individual patient needs is improved, but time consumption and patient burden increase
Solution Approach 1:
The system performs preliminary analysis of patient data, physiological patterns, and metabolic characteristics to pre-calculate optimal insulin dosage recommendations before they are needed. By anticipating patient needs and pre-processing data, the system reduces the time required for real-time dosage adjustments while maintaining high adaptability to individual patient needs
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A diagnosis, therapy and prognosis system (DTPS) and method thereof to help either the healthcare provider or the patient in diagnosing, treating and interpreting data are disclosed. The apparatus provides data collection based on protocols, and mechanism for testing data integrity and accuracy. The data is then driven through an analysis engine to characterize in a quantitative sense the metabolic state of the patient's body. The characterization is then used in diagnosing the patient, determining therapy, evaluating algorithm strategies and offering prognosis of potential use case scenarios.